SRAX (SRAX) Stock Forecast, Price Target & Predictions
SRAX Stock Forecast
SRAX stock forecast is as follows: an average price target of $6.00 (represents a 3900.00% upside from SRAX’s last price of $0.15) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
SRAX Price Target
The average price target for SRAX (SRAX) is $6.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 3900.00% upside from SRAX's last price of $0.15.
SRAX Analyst Ratings
According to 2 Wall Street analysts, SRAX's rating consensus is 'Buy'. The analyst rating breakdown for SRAX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
SRAX Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 26, 2022 | - | Raymond James | $6.00 | $1.96 | 206.12% | 3900.00% |
The latest SRAX stock forecast, released on Sep 26, 2022 by Raymond James company, set a price target of $6.00, which represents a 206.12% increase from the stock price at the time of the forecast ($1.96), and a 3900.00% increase from SRAX last price ($0.15).
SRAX Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.15 | $0.15 | $0.15 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of SRAX stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SRAX's last price of $0.15. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jan 13, 2023 | B. Riley Securities | Buy | Buy | Hold |
| Sep 26, 2022 | Dawson James | Buy | Buy | Hold |
SRAX's last stock rating was published by B. Riley Securities on Jan 13, 2023. The company gave SRAX a "Buy" rating, the same as its previous rate.
SRAX Financial Forecast
SRAX Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 20 | Sep 19 | Jun 19 | Sep 17 | Jun 17 | Mar 17 | Dec 16 | Sep 16 | Jun 16 | Mar 16 | Sep 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $7.50M | $9.59M | $8.31M | $7.68M | $5.44M | $1.17M | $1.00M | $904.22K | $5.55M | $5.98M | $5.33M | $11.51M | $9.53M | $9.25M | $5.47M | $7.39M |
| Avg Forecast | $7.60M | $7.27M | $6.02M | $10.34M | $9.75M | $9.84M | $9.39M | $8.11M | $10.80M | $7.50M | $7.50M | $12.56M | $8.25M | $8.25M | $4.52M | $797.11K | $1.55M | $397.38K | $333.00K | $6.64M | $2.67M | $13.43M | $9.23M | $2.47M | $683.75K | $14.78M |
| High Forecast | $7.60M | $7.27M | $7.22M | $10.34M | $9.75M | $9.84M | $9.39M | $8.11M | $10.80M | $7.50M | $9.00M | $15.07M | $9.90M | $9.90M | $5.43M | $956.52K | $1.86M | $476.85K | $399.60K | $7.97M | $3.20M | $16.12M | $11.08M | $2.96M | $820.50K | $17.74M |
| Low Forecast | $7.60M | $7.27M | $4.82M | $10.34M | $9.75M | $9.84M | $9.39M | $8.11M | $10.80M | $7.50M | $6.00M | $10.05M | $6.60M | $6.60M | $3.62M | $637.68K | $1.24M | $317.90K | $266.40K | $5.32M | $2.13M | $10.75M | $7.38M | $1.97M | $547.00K | $11.82M |
| # Analysts | 9 | 9 | 19 | 10 | 14 | 18 | 9 | 8 | 8 | 1 | 1 | 19 | 13 | 18 | 12 | 11 | 15 | 13 | 15 | 17 | 12 | 17 | 15 | 20 | 18 | 15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.76% | 1.01% | 0.93% | 1.20% | 1.46% | 0.65% | 2.28% | 16.68% | 0.90% | 2.00% | 0.86% | 1.03% | 3.75% | 8.00% | 0.50% |
SRAX's average Quarter revenue forecast for Jun 22 based on 1 analysts is $7.50M, with a low forecast of $7.50M, and a high forecast of $7.50M. SRAX's average Quarter revenue forecast represents a 0.01% increase compared to the company's last Quarter revenue of $7.50M (Mar 22).
SRAX EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 20 | Sep 19 | Jun 19 | Sep 17 | Jun 17 | Mar 17 | Dec 16 | Sep 16 | Jun 16 | Mar 16 | Sep 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 19 | 10 | 14 | 18 | 9 | 8 | 8 | 1 | 1 | 19 | 13 | 18 | 12 | 11 | 15 | 13 | 15 | 17 | 12 | 17 | 15 | 20 | 18 | 15 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-1.01M | $615.00K | $43.00K | $-689.00K | $-1.01M | $-3.32M | $1.82M | $-7.64M | $-3.31M | $-231.42K | $-1.20M | $-749.37K | $-3.35M | $1.20M | $-1.42M | $-1.47M |
| Avg Forecast | $-4.71M | $-4.50M | $-3.73M | $-6.40M | $-6.04M | $-6.10M | $-5.82M | $-5.03M | $-27.60M | $-32.03M | $-4.65M | $-817.43K | $-25.09M | $-34.26M | $-2.80M | $-1.97M | $-958.44K | $-12.13M | $-55.68M | $-254.56K | $-1.32M | $-874.26K | $-2.21M | $-1.53M | $-7.65M | $-626.94K |
| High Forecast | $-4.71M | $-4.50M | $-2.98M | $-6.40M | $-6.04M | $-6.10M | $-5.82M | $-5.03M | $-22.08M | $-25.62M | $-3.72M | $-653.95K | $-20.08M | $-27.41M | $-2.24M | $-1.57M | $-766.75K | $-9.71M | $-44.55M | $-203.65K | $-1.06M | $-699.41K | $-1.77M | $-1.22M | $-6.12M | $-501.55K |
| Low Forecast | $-4.71M | $-4.50M | $-4.47M | $-6.40M | $-6.04M | $-6.10M | $-5.82M | $-5.03M | $-33.12M | $-38.44M | $-5.58M | $-980.92K | $-30.11M | $-41.11M | $-3.36M | $-2.36M | $-1.15M | $-14.56M | $-66.82M | $-305.47K | $-1.59M | $-1.05M | $-2.65M | $-1.83M | $-9.18M | $-752.33K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.22% | -0.75% | -0.00% | 0.02% | 0.36% | 1.69% | -1.90% | 0.63% | 0.06% | 0.91% | 0.91% | 0.86% | 1.52% | -0.79% | 0.19% | 2.34% |
1 analysts predict SRAX's average Quarter EBITDA for Mar 22 to be $-4.65M, with a high of $-3.72M and a low of $-5.58M. This is -855.55% lower than SRAX's previous annual EBITDA (Dec 21) of $615.00K.
SRAX Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 20 | Sep 19 | Jun 19 | Sep 17 | Jun 17 | Mar 17 | Dec 16 | Sep 16 | Jun 16 | Mar 16 | Sep 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 19 | 10 | 14 | 18 | 9 | 8 | 8 | 1 | 1 | 19 | 13 | 18 | 12 | 11 | 15 | 13 | 15 | 17 | 12 | 17 | 15 | 20 | 18 | 15 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $3.73M | $610.00K | $-3.83M | $-10.57M | $-7.45M | $-5.32M | $1.41M | $-8.10M | $-4.07M | $-737.69K | $-2.03M | $-1.34M | $-2.38M | $1.87M | $-2.40M | $-658.54K |
| Avg Forecast | $40.50M | $35.25M | $-52.94M | $682.25K | $900.88K | $1.09M | $-48.13M | $2.09M | $-36.01M | $-36.68M | $-43.75M | $-1.47M | $-32.74M | $-39.23M | $-39.77M | $-3.15M | $3.36M | $-12.86M | $-68.45M | $-811.46K | $-2.23M | $-1.57M | $-2.30M | $2.95M | $-12.97M | $-889.03K |
| High Forecast | $40.50M | $35.25M | $-42.35M | $682.25K | $900.88K | $1.09M | $-38.50M | $2.09M | $-28.81M | $-29.34M | $-35.00M | $-1.17M | $-26.19M | $-31.38M | $-31.82M | $-2.52M | $4.03M | $-10.29M | $-54.76M | $-649.16K | $-1.78M | $-1.25M | $-1.84M | $3.54M | $-10.38M | $-711.22K |
| Low Forecast | $40.50M | $35.25M | $-63.53M | $682.25K | $900.88K | $1.09M | $-57.75M | $2.09M | $-43.21M | $-44.01M | $-52.50M | $-1.76M | $-39.29M | $-47.07M | $-47.73M | $-3.78M | $2.69M | $-15.44M | $-82.14M | $-973.75K | $-2.67M | $-1.88M | $-2.76M | $2.36M | $-15.56M | $-1.07M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | -0.09% | -0.42% | 0.12% | 0.27% | 0.19% | 1.69% | 0.42% | 0.63% | 0.06% | 0.91% | 0.91% | 0.86% | 1.03% | 0.63% | 0.19% | 0.74% |
SRAX's average Quarter net income forecast for Jun 22 is $-36.68M, with a range of $-44.01M to $-29.34M. SRAX's average Quarter net income forecast represents a -1083.86% decrease compared to the company's last Quarter net income of $3.73M (Mar 22).
SRAX SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 20 | Sep 19 | Jun 19 | Sep 17 | Jun 17 | Mar 17 | Dec 16 | Sep 16 | Jun 16 | Mar 16 | Sep 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 19 | 10 | 14 | 18 | 9 | 8 | 8 | 1 | 1 | 19 | 13 | 18 | 12 | 11 | 15 | 13 | 15 | 17 | 12 | 17 | 15 | 20 | 18 | 15 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $5.84M | $6.87M | $7.74M | $6.92M | $4.83M | $3.70M | $5.39M | $5.11M | $3.66M | $3.34M | $4.41M | $5.57M | $3.85M | $3.43M | $3.81M | $3.75M |
| Avg Forecast | $15.74M | $15.05M | $12.47M | $21.41M | $20.20M | $20.38M | $19.46M | $16.80M | $22.38M | $15.54M | $15.54M | $6.07M | $17.09M | $17.09M | $9.37M | $1.65M | $3.20M | $823.14K | $689.79K | $3.68M | $5.52M | $6.49M | $3.73M | $5.11M | $1.42M | $5.06M |
| High Forecast | $15.74M | $15.05M | $14.96M | $21.41M | $20.20M | $20.38M | $19.46M | $16.80M | $22.38M | $15.54M | $18.64M | $7.29M | $20.51M | $20.51M | $11.24M | $1.98M | $3.85M | $987.76K | $827.75K | $4.41M | $6.62M | $7.79M | $4.47M | $6.13M | $1.70M | $6.08M |
| Low Forecast | $15.74M | $15.05M | $9.97M | $21.41M | $20.20M | $20.38M | $19.46M | $16.80M | $22.38M | $15.54M | $12.43M | $4.86M | $13.67M | $13.67M | $7.49M | $1.32M | $2.56M | $658.51K | $551.83K | $2.94M | $4.42M | $5.20M | $2.98M | $4.09M | $1.13M | $4.05M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.38% | 1.13% | 0.45% | 0.40% | 0.52% | 2.24% | 1.68% | 6.21% | 5.30% | 0.91% | 0.80% | 0.86% | 1.03% | 0.67% | 2.69% | 0.74% |
SRAX's average Quarter SG&A projection for Jun 22 is $15.54M, based on 1 Wall Street analysts, with a range of $15.54M to $15.54M. The forecast indicates a 165.93% rise compared to SRAX last annual SG&A of $5.84M (Mar 22).
SRAX EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Jun 20 | Sep 19 | Jun 19 | Sep 17 | Jun 17 | Mar 17 | Dec 16 | Sep 16 | Jun 16 | Mar 16 | Sep 15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 19 | 10 | 14 | 18 | 9 | 8 | 8 | 1 | 1 | 19 | 13 | 18 | 12 | 11 | 15 | 13 | 15 | 17 | 12 | 17 | 15 | 20 | 18 | 15 |
| EPS | - | - | - | - | - | - | - | - | - | - | $0.14 | $0.02 | $-0.30 | $-0.45 | $-0.38 | $-0.38 | $0.11 | $-0.67 | $-0.50 | $-0.09 | $-0.26 | $-0.20 | $-0.40 | $0.30 | $-0.40 | $-0.10 |
| Avg Forecast | $1.54 | $1.34 | $1.57 | $0.03 | $0.03 | $0.04 | $0.02 | $0.08 | $0.02 | $0.10 | $0.15 | $1.89 | $1.25 | $1.01 | $-0.33 | $-0.15 | $-0.41 | $-0.27 | $0.50 | $-0.11 | $-0.14 | $-0.28 | $-0.22 | $0.13 | $-0.27 | $-0.27 |
| High Forecast | $1.54 | $1.34 | $1.57 | $0.03 | $0.03 | $0.04 | $0.02 | $0.08 | $0.02 | $0.10 | $0.19 | $2.38 | $1.57 | $1.27 | $-0.27 | $-0.12 | $-0.32 | $-0.22 | $0.60 | $-0.09 | $-0.11 | $-0.22 | $-0.18 | $0.15 | $-0.22 | $-0.22 |
| Low Forecast | $1.54 | $1.34 | $1.57 | $0.03 | $0.03 | $0.04 | $0.02 | $0.08 | $0.02 | $0.10 | $0.11 | $1.40 | $0.92 | $0.75 | $-0.40 | $-0.18 | $-0.49 | $-0.32 | $0.40 | $-0.13 | $-0.17 | $-0.34 | $-0.27 | $0.10 | $-0.32 | $-0.32 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 0.93% | 0.01% | -0.24% | -0.45% | 1.15% | 2.53% | -0.27% | 2.48% | -1.00% | 0.82% | 1.86% | 0.71% | 1.82% | 2.31% | 1.48% | 0.37% |
According to 1 Wall Street analysts, SRAX's projected average Quarter EPS for Jun 22 is $0.10, with a low estimate of $0.10 and a high estimate of $0.10. This represents a -28.57% decrease compared to SRAX previous annual EPS of $0.14 (Mar 22).
SRAX Forecast FAQ
Is SRAX a good buy?
Yes, according to 2 Wall Street analysts, SRAX (SRAX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of SRAX's total ratings.
What is SRAX's price target?
SRAX (SRAX) average price target is $6 with a range of $6 to $6, implying a 3900.00% from its last price of $0.15. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will SRAX stock go up soon?
According to Wall Street analysts' prediction for SRAX stock, the company can go up by 3900.00% (from the last price of $0.15 to the average price target of $6), up by 3900.00% based on the highest stock price target, and up by 3900.00% based on the lowest stock price target.
Can SRAX stock reach $0?
SRAX's average twelve months analyst stock price target of $6 supports the claim that SRAX can reach $0 in the near future.
What are SRAX's analysts' financial forecasts?
SRAX's analysts financial forecasts for the fiscal year (Dec 2022) are as follows: average revenue is $33.92M (high $35.42M, low $32.42M), average EBITDA is $-69.306M (high $-56.45M, low $-82.162M), average net income is $-114M (high $-91.067M, low $-138M), average SG&A $70.26M (high $73.37M, low $67.15M), and average EPS is $0.349 (high $0.388, low $0.31). SRAX's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $39.32M (high $39.32M, low $39.32M), average EBITDA is $-24.362M (high $-24.362M, low $-24.362M), average net income is $-45.452M (high $-35.827M, low $-55.077M), average SG&A $81.45M (high $81.45M, low $81.45M), and average EPS is $0.118 (high $0.118, low $0.118).
Did the SRAX's actual financial results beat the analysts' financial forecasts?
Based on SRAX's last annual report (Dec 2021), the company's revenue was $28.55M, which missed the average analysts forecast of $33.58M by -14.98%. Apple's EBITDA was $2.8M, missing the average prediction of $-62.97M by -104.44%. The company's net income was $1.96M, missing the average estimation of $-113M by -101.73%. Apple's SG&A was $19.46M, missing the average forecast of $49.62M by -60.78%. Lastly, the company's EPS was $-1.48, missing the average prediction of $3.82 by -138.76%. In terms of the last quarterly report (Mar 2022), SRAX's revenue was $7.5M, missing the average analysts' forecast of $7.5M by -0.01%. The company's EBITDA was $-1.013M, missing the average prediction of $-4.647M by -78.20%. SRAX's net income was $3.73M, missing the average estimation of $-43.751M by -108.52%. The company's SG&A was $5.84M, missing the average forecast of $15.54M by -62.40%. Lastly, the company's EPS was $0.14, missing the average prediction of $0.15 by -6.67%